Effect of estrogen on electroretinographic responses in streptozotocin-induced diabetic female rats

Experimental Eye Research

Volumn 90, Issue 5, 2010, Pages 591-597

  Yamashita, Haruhiro ^a   Sugihara, Kazunari ^a   Yamada, Chiaki ^a   Tsutsumi, Shunsuke ^a   Iwaki, Yoshinobu ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Estrogen deficiency; Full field ERG; Rat retina; STZ induced diabetic rat

Indexed keywords

ESTROGEN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; ESTROGEN DEFICIENCY; FEMALE; HORMONE RESPONSE; NONHUMAN; OSCILLATORY POTENTIAL; OVARIECTOMY; PHOTOPIC VISION; PRIORITY JOURNAL; RAT; RETINA CONE; STREPTOZOCIN DIABETES; ANIMAL; BODY WEIGHT; CATARACT; CORNEA DISEASE; EXPERIMENTAL DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; LONG EVANS RAT; OVARY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CATARACT; CORNEAL DISEASES; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; ESTROGENS; FEMALE; OVARIECTOMY; OVARY; RATS; RATS, LONG-EVANS; RETINA;

EID: 77951234390     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2010.02.003     Document Type: Article

References (47)

1. Asi H., Perlman I. The relationships between the ERG a-wave, b-wave and oscillatory potentials and their application to clinical diagnosis. Doc. Ophthalmol. 1992, 79:125-139.
2. Bigsby R.M., Cardenas H., Caperell-Grant A., Grubbs C.J. Protective effects of estrogen in a rat model of age-related cataracts. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:9328-9332.
3. Bresnick G.H., Korth K., Groo A., Palta M. Electroretinographic oscillatory potentials predict progression of diabetic retinopathy. Preliminary report. Arch. Ophthalmol. 1987, 102:1307-1311.
4. Bresnick G.H., Palta M. Temporal aspects of the electroretinogram in diabetic retinopathy. Arch. Ophthalmol. 1987, 105:660-664.
5. Brûlé J., Lavoie M.P., Casanova C., Lachapelle P., Hébert M. Evidence of a possible impact of the menstrual cycle on the reproducibility of scotopic ERGs in women. Doc. Ophthalmol. 2007, 114:125-134.
6. Carrer H.F., Cambiasso M.J. Sexual differentiation of the brain: genes, estrogen, and neurotrophic factors. Cell. Mol. Neurobiol. 2002, 22:479-500.
7. Cruz R.D., Adachi-Usami E. Quantitative evaluation of electroretinogram before cataract surgery. Jpn. J. Ophthalmol. 1989, 33:451-457.
8. Dai Y., Ou-Yang J., Chen X.-H., Wang X.-L. Effects of estrogen on retinal light injury. Int. J. Ophthalmol. 2008, 8:1165-1166.
9. Ewing F.M.E., Deary I.J., Strachan M.W.J., Frier B.M. Seeing beyond retinopathy in diabetes: electrophysiological and psychophysical abnormalities and alterations in vision. Endocr. Rev. 1998, 19:462-476.
10. Fraser-Bell S., Wu J., Klein R., Azen S.P., Varma R. Smoking, alcohol intake, estrogen use, and age-related macular degeneration in latinos: the Los Angeles Latino Eye Study. Am. J. Ophthalmol. 2006, 141:79-87.
11. Garcia-Segura L.M., Azcoitia I., DonCarlos L.L. Neuroprotection by estradiol. Prog. Neurobiol. 2001, 63:29-60.
12. Garner A. Histopathology of diabetic retinopathy in man. Eye 1993, 7:250-253.
13. Ghirlanda G., Di Leo M.A.S., Caputo S., Falsini B., Porciatti V., Marietti G., Greco A.V. Detection of inner retina dysfunction by steady-state focal electroretinogram pattern and flicker in early IDDM. Diabetes 1991, 40:1122-1127.
14. Hancock H.A., Kraft T.W. Oscillatory potential analysis and ERGs of normal and diabetic rats. Invest. Ophthalmol. Vis. Sci. 2004, 45:1002-1008.
15. Holopigian K., Seiple W., Lorenzo M., Carr R. A comparison of photopic and scotopic electroretinographic changes in early diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 1992, 33:2773-2780.
16. Imesch P.D., Bindley C.D., Wallow I.H.L. Cliniocopathologic correlation of intraretinal microvascular abnormalities. Retina 1997, 17:321-329.
17. Ishikawa A., Ishiguro S.I., Tamai M. Changes in GABA metabolism in streptozotocin-induced diabetic rat retinas. Curr. Eye Res. 1996, 15:63-71.
18. Kim S.H., Lee S.H., Bae J.Y., Cho J.H., Kang Y.S. Electroretinographic evaluation in adult diabetics. Doc. Ophthalmol. 1997, 94:201-213.
19. Kiyosawa I. Age-related changes in visual function and visual organs of rats. Exp. Anim. 1996, 45:103-114.
20. Klein B.E.K., Klein R., Moss S.E. Exogenous estrogen exposures and changes in diabetic retinopathy. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care 1999, 22:1984-1987.
21. Klemp K., Sander B., Brockhoff P.B., Vaag A., Lund-Andersen H., Larsen M. The multifocal ERG in diabetic patients without retinopathy during euglycemic clamping. Invest. Ophthalmol. Vis. Sci. 2005, 46:2620-2626.
22. Kobayashi K., Kobayashi H., Ueda M., Honda Y. Estrogen receptor expression in bovine and rat retinas. Invest. Ophthalmol. Vis. Sci. 1998, 39:2105-2110.
23. Kooijman A.C., Damhof A. ERG lens with built-in Ganzfeld light source for stimulation and adaptation. Invest. Ophthalmol. Vis. Sci. 1980, 19:315-318.
24. Layton C.J., Chidlow G., Casson R.J., Wood J.P.M., Graham M., Osborne N.N. Monocarboxylate transporter expression remains unchanged during the development of diabetic retinal neuropathy in the rat. Invest. Ophthalmol. Vis. Sci. 2005, 46:2878-2885.
25. Li C., Tang Y., Li F., Turner S., Li K., Zhou X., Centola M., Yan X., Cao W. 17β-estradiol (βE2) protects human retinal Müller cell against oxidative stress in vitro: evaluation of its effects on gene expression by cDNA microarray. Glia 2006, 53:392-400.
26. Li Q., Zemel E., Miller B., Perlman I. Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp. Eye Res. 2002, 74:615-625.
27. Lieth E., Barber A.J., Xu B., Dice C., Ratz M.J., Tanase D., Strother J.M. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy: Penn State Retina Research Group. Diabetes 1998, 47:815-820.
28. Lovasik J.V., Spafford M.M. An electrophysiological investigation of visual function in juvenile insulin-dependent diabetic mellitus. Am. J. Optom. Physiol. Opt. 1988, 65:236-253.
29. Lovasik J.V., Spafford M.M. Electrophysiological changes in juvenile diabetics without retinopathy. Arch. Ophthalmol. 1990, 108:372-375.
30. Mizutani M., Kern T.S., Lorenzi M. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. J. Clin. Invest. 1996, 97:2883-2890.
31. Moosmann B., Behl C. Antioxidants as treatment for neurodegenerative disorders. Expert Opin. Inbestig. Drugs 2002, 11:1407-1435.
32. Nakazawa T., Takahashi H., Shimura M. Estrogen has a neuroprotective effect on axotomized RGCs through ERK signal transduction pathway. Brain Res. 2006, 1093:141-149.
33. Park S.H., Park J.W., Park S.J., Kim K.Y., Chung J.W., Chun M.H., Oh S.J. Apoptotic death of photoreceptors in the streptozotocin-induced diabetic rat retina. Diabetologia 2003, 46:1260-1268.
34. Phipps J.A., Fletcher E.L., Vingrys A.J. Paired-flash identification of rod and cone dysfunction in the diabetic rat. Invest. Ophthalmol. Vis. Sci. 2004, 45:4592-4600.
35. Ramsey D.J., Ripps H., Qian H. An electrophysiological study of retinal function in the diabetic female rat. Invest. Ophthalmol. Vis. Sci. 2006, 47:5116-5124.
36. Rungger-Brändle E., Dosso A.A., Leuenberger P.M. Glial reactivity, an early feature of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2000, 41:1971-1980.
37. Russo R., Cavaliere F., Watanabe C., Nucci C., Bagetta G., Corasaniti M.T., Sakurada S., Morrone L.A. 17β-Estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat. Prog. Brain Res. 2008, 173:583-590.
38. Simonsen S.E. The value of the oscillatory potential in selecting juvenile diabetics at risks of developing proliferative diabetic retinopathy. Acta Ophthalmol. 1980, 58:865-877.
39. Sperduto Risk factors for central retinal vein occlusion the eye disease case-control study group. Arch. Ophthalmol. 1996, 114:545-554.
40. Sperduto R.D., Yannuzzi L.A., Sorenson J.A., et al. Risk factors for neovascular age-related macular degeneration. Arch. Ophthalmol. 1992, 110:1701-1708.
41. Tahara K., Matsuura T., Otori T. Diagnostic evaluation of diabetic retinopathy by 30-Hz flicker electroretinography. Jpn. J. Ophthalmol. 1993, 37:204-210.
42. Tyrberg M., Ponjavic V., Lövestam-Adrian M. Multifocal electroretinography (mfERG) in insulin dependent diabetics with and without clinically apparent retinopathy. Doc. Ophthalmol. 2005, 110:137-143.
43. Tzekov R., Arden G.B. The electroretinogram in diabetic retinopathy. Surv. Ophthalmol. 1999, 44:53-60.
44. Yamashita H., Yamasaki K., Sugihara K., Miyata H., Tsutsumi S., Iwaki Y. Full-field electroretinography obtained using a contact lens electrode with built-in high-intensity white-light-emitting diodes can be utilized in toxicological assessments in rats. Ophthalmic Res. 2009, 42:15-20.
45. Yannuzzi L.A., Sorenson J.A., Sobel R.S., et al. Risk factors for idiopathic macular holes. Am. J. Optom. Physiol. Opt. 1994, 118:754-761.
46. Yonemura D., Kawasaki K. New approaches to ophthalmic electrodiagnosis by retinal oscillatory potential, drug-induced responses from retinal pigment epithelium and cone potential. Doc. Ophthalmol. 1979, 48:163-222.
47. Zhou X., Li F., Ge J., Sarkisian S.R., Tomita H., Zaharia A., Chodosh J., Cao W. Retinal ganglion cell protection by 17-β-estradiol in a mouse model of inherited glaucoma. Dev. Neurobiol. 2007, 67:603-616.